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Abstract 
Background and Aim: One of the side effects of anticancer drugs is spermatogenesis disorder. Hence, the evaluation 
of sperm production after chemotherapy has been the subject of several studies today. 
Methods: Adult male albino mice weighing 20±2 g were randomly divided into 5 groups (n = 4);control, 
cyclophosphamide (12 mg/kg/day), cyclophosphamide and vitamin E (200 mg/kg/day), cyclophosphamide and 
retinoic acid (500 µL/72h), cyclophosphamide and retinoic acid (250 µL/72h) and vitamin E (100 mg/day). The 
treatment was continued for 35 days and at the end of the rats was anesthetized and testicular tissue was isolated, 
weighed, fixed, and stained with hematoxylin-eosin. 
Results: A significant decrease (p-value ≤ 0.0001) in the mean diameter of seminal vesicles, epithelial thickness, and 
index of tubular differentiation was observed in the testis tissue of mice treated with cyclophosphamide compared to 
the control group. In cyclophosphamide recipients with retinoic acid or vitamin E, parameters significantly increased 
to the level of the control group (p-value ≤ 0.0001), whereas cyclophosphamide co-administration with retinoic acid 
and vitamin A had a less tissue-protective effect. 
Conclusion: Vitamin E and retinoic acid can offset the adverse effects of cyclophosphamide on spermatogenesis and 
may be inducers of spermatogenesis, while the combination of these two antioxidants has fewer efficacies . 
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Introduction 
Chemotherapy is a common way to treat various 
cancers to control and inhibit the proliferation of 
cancer cells and, albeit, has known side effects on 
Spermatogenesis. Since reproduction and fertility 
are essential human biological processes and 
infertility has always been one of the leading social 
and medical problems, attention to spermatogenesis 
recovery after chemotherapy courses is one of the 
critical and modern aspects of infertility studies (1). 
Among the side effects of chemotherapy drugs, 
oxidative stress damages spermatozoa and reduces 
fertility. Like other chemotherapeutic drugs, 
cyclophosphamide has a disruptive impact on other 
tissues in the body. It can upset the redox balance of 
testicular tissue and cause the accumulation of free 
radicals and oxidative stress factors in the testis. 
Therefore, applying antioxidants that prevent the 
formation of free radicals in cells and the 
occurrence of chain reactions of oxidation can 
reduce the tissue damage caused by its consumption 
(2). Cyclophosphamide is an anti-tumor and 
immunosuppressive compound that targets fast-
growing cells. It is used in high doses to treat 
various cancers, including malignant lymphoma, 
multiple myeloma, and leukemia, and in low doses 
to treat a type of lupus. In hepatocyte cells, the drug 
is converted to an active metabolite by cytochrome 
p450 enzymes and returned to the bloodstream (3). 
Cyclophosphamide causes the accumulation of free 
radicals and oxidative stress in the testicles. Finally, 
the accumulation of these compounds leads to DNA 
fragmentation and loss of normal sperm function 
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and mitochondrial peroxidative damage, and 
membrane breakdown.  
Cyclophosphamide also reduces the thickness of the 
epithelial layers of seminiferous tubules, and 
histological complications associated with this drug 
include the presence of irregular, fibrotic, and 
perivascular seminiferous tubules in the testis (4). 
In addition to investigating the effects of 
cyclophosphamide in this study, two potent 
antioxidant agents were used separately and 
together to support the spermatogenesis of small 
rats in the laboratory while receiving chemotherapy. 
The purpose of the experiments was to investigate 
the role of each factor in preventing damage caused 
by oxidative stress in testicular tissue and also to 
investigate the simultaneous administration of 
vitamin E and retinoic acid as a combined 
antioxidant treatment. Vitamin E is a well-known 
antioxidant, and a necessary factor in relieving 
oxidative stress, and retinoic acid is an imperative 
and useful factor in the development and regulation 
of male reproductive system activity. Vitamin E 
inhibits fat peroxidation in mitochondria and 
testicular microsomes and reduces the destructive 
effects of oxidative stress caused by stressors (5-7). 
Low doses of retinoic acid since 1987 (discovery of 
nuclear receptors) have been identified as required 
factors in stimulating growth, cartilage formation, 
and cell proliferation. Researchers have done 
extensive research on the regulation of intracellular 
retinoid concentrations and their role in the cell. 
This antioxidant is useful in many vital activities of 
the body, such as growth and immune system, and 
reproductive system, and prevents lipid 
peroxidation in the testicles. It improves 
Spermatogenesis and the structural differentiation 
of epididymal epithelial cells during embryonic 
development and testicular tissue development (8-
10). Therefore, this study aims to find a logical 
answer for prescribing the therapeutic use of these 
vitamins separately and together during 
chemotherapy courses. The results will promote 
molecular studies and signaling pathways related to 
cell proliferation and preservation. 
Methods 
To investigate the effects of retinoic acid and 
vitamin E on cyclophosphamide-induced 
spermatogenesis disorder, a total of twenty 
adult male albino mice (4 to 6 weeks old; 
25±2 g body weight) were housed at 23±2°C 
on a 12 h light/dark cycle). After one-week 
adaptation period, mice were categorized into 
5 groups as follows: 
1. Control group: no drug treatment; 
2. Treatment group: cyclophosphamide; 
3. Co-treatment group: cyclophosphamide 
(12 mg/kg/day) and vitamin E (200mg/kg/day); 
4. Co-treatment group: cyclophosphamide 
(12 mg/kg/day) and retinoic acid (500 μl/72 h); 
5. Co-treatment group: cyclophosphamide 
(12mg/kg/day) with retinoic acid (250 μl/72 h) and 
vitamin E (100 mg/kg/day). 
It should be noted that all treatments were injected 
intraperitoneal 
Cyclophosphamide powder was prepared by 
dissolving in saline at the mentioned concentration, 
and the volume of each injection was 0.3 ml 
intraperitoneally. Retinoic acid is also dissolved in a 
mixture of Corn oil and absolute ethanol and is 
administered as 0.3 ml intraperitoneally. Vitamin E 
was also administered intraperitoneally 0.1 ml in 
each injection.  
Mice were humanely killed after the treatment was 
completed, and the testicular tissues were isolated 
and stabilized in a 10% formalin solution. 
Subsequently, the incisions were made by 




The microscopic examination results of tissues were 
analyzed by SPSS 22 statistical software. For 
calculating the tubular differentiation index, the 
percentage of sperm-forming tubes containing three 
or more rows of spermatogenic cells differentiated 
from spermatogonia was calculated. For assessing 
the RI index, the ratio of active spermatogonia cells 
to inactive spermatogonia cells in seminiferous 
tubules was calculated. For obtaining the 
spermiogenesis coefficient, the ratio of semen-
producing tubes containing sperm to sperm fewer 
tubes was calculated. The comparison of the TDI 
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(Tubular differentiation Index) in different groups 
showed that in rats treated with methylphenidate, 
this index was decreased. 
Results 
Evaluated parameters in this study were as follows:  
measuring the small and large diameter of 
Seminiferous tubules in H&E testicular tissue 
laminae, measuring the thickness of seminiferous 
epithelium in central and peripheral tubes of H&E 
testicular tissue laminae, evaluating the density of 
seminiferous tubules per testicular tissue unit. The 
TDI index or tubular differentiation index and the 
qualitative study of the changes in the 
histopathological changes of the testicular tissue 
were performed by a pathologist and based on the 
results of statistical analyzes, a significant data 
coefficient (p-value≤0.0001) was recorded. The 
results are comparable in the following diagrams 
and illustrations. In the charts, the groups from A to 
E, respectively, include: 
Control group, cyclophosphamide receiving group, 
cyclophosphamide and vitamin E receiving group, 
cyclophosphamide and retinoic acid receiving 
group, cyclophosphamide, and both antioxidants 
receiving group.  
 
Figure 1. Comparison of the large diameter of testicular 
seminiferous tubules in terms of the micrometer in different 
groups whit control group. 
*p-value=0.085; **p-value ≤0.0001; ***p-value ≤0.0001 
Each bar represents mean ± SD 
A: Control group; 
B: Cyclophosphamide receiving group;  
C: Cyclophosphamide and vitamin receiving group;  
D: Cyclophosphamide and retinoic acid receiving group; 





Figure 2. Comparison of the small diameter of testicular 
seminiferous tubules in terms of the micrometer in different 
groups with the control group 
*p-value≤0.0001); **p-value≤0.0001); ***p-value≤0.0001 
Each bar represents mean ± SD 
A: Control group; B: Cyclophosphamide receiving group;  
C: Cyclophosphamide and vitamin receiving group; 
D: Cyclophosphamide and retinoic acid receiving group; 
E: Cyclophosphamide, and both antioxidants receiving group;  
Figure 3. Comparison of the epithelial thickness of peripheral 
testicular seminiferous tubules in terms of micrometers in 
different groups whit control group whit control group 
*p-value=0.003; **p-value≤0.0001; ***p-value≤0.0001 
Each bar represents a mean ± SD 
A: Control group;  
B: Cyclophosphamide receiving group;  
C: Cyclophosphamide and vitamin receiving group; 
D: Cyclophosphamide and retinoic acid receiving group;  
E: Cyclophosphamide, and both antioxidants receiving group. 
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Figure 4. Comparison of the epithelial thickness of central 
testicular seminiferous tubules in terms of the micrometer in 
different groups whit control group 
*p-value≤0.0001); **p-value≤0.0001; ***p-value≤0.0001. 
Each bar represents the mean ± SD 
A: Control group;  
B: Cyclophosphamide receiving group;  
C: Cyclophosphamide and vitamin receiving group; 
D: Cyclophosphamide and retinoic acid receiving group;  
E: Cyclophosphamide, and both antioxidants receiving group. 
Figure 5. Comparison of TDI index by percentage in testicular 
seminiferous tubules in different groups whit control group 
*p-value=0.218; **p-value=0.029; ***p-value≤0.0001 
Each bar represents mean ± SD 
A: Control group;  
B: Cyclophosphamide receiving group;  
C: Cyclophosphamide and vitamin receiving group; 
D: Cyclophosphamide and retinoic acid receiving group; 
E: Cyclophosphamide, and both antioxidants receiving group. 
 
 
Figure 6. Comparison of the percentage of the density of 
seminiferous tubules per unit area of testicular tissue in different 
groups whit Control group 
*p-value=0.033; **p-value=0.036; ***p-value ≤0.0001 
Each bar represents mean ± SD 
A: Control group;  
B: Cyclophosphamide receiving group;  
C: Cyclophosphamide and vitamin receiving group;  
D: Cyclophosphamide and retinoic acid receiving group;  
E: Cyclophosphamide, and both antioxidants receiving group; 
 
  
Figure 7. A, transverse section of the seminiferous tube in the control group; The seminiferous tubules were normal, and the 
tubular epithelium was thick [H&E staining (magnification 40 x)] B, transverse section of the seminiferous tube of the 
cyclophosphamide-receiving group. The epithelial thickness and the magnitude decreased [H&E staining (magnification 40 x)]. 
 
A B 
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Figure 8. A, the transverse section of the seminiferous tube of the Cyclophosphamide and vitamin E receiving group; the regular 
arrangement of different cell categories are observed. [H&E staining (magnification 40 x)] B, transverse section of the seminiferous 
tube of the Cyclophosphamide and retinoic acid receiving group; Disorders of the Leidig cells, atrophy, and tubal deformation 
[H&E staining (magnification 40 x)]. 
 
 
Figure 9. Transverse section of the seminiferous tube of the 
Cyclophosphamide- and the combination of vitamin E and 
retinoic acid receiving group. Decreased epithelial thickness 
and irregularity and increased diameter are observed [H&E 
staining (magnification 40 x)]. 
Discussion 
In the vitamin E receiving group, the most 
significant effect of tissue support was observed 
(237.05 microns). This effect is such that the 
diameter is close to the control group (243.85 
microns). In the retinoic acid (217.00 microns) and 
the combination of vitamin E and retinoic acid 
(222.35 microns) receiving groups, the increase in 
diameter has been significant, and these two 
treatments have almost given the same and close 
effect. In the case of small diameters of 
seminiferous tubules, the data showed a meaningful 
reduction in the group receiving Cyclophosphamide 
(147.35 microns), and the most excellent result of 
diameter increasing was monitored in the group 
receiving vitamin E (174 microns), which is closer 
to the control group (182.30 microns). This increase 
was in the retinoic acid (160.80 microns)-receiving 
group, while in the retinoic acid and vitamin E co-
treatment group, the supportive effect was slightly 
milder (157.35 microns). The epithelial thickness 
average of peripheral seminiferous tubules in the 
CP receiving group decreased significantly. It 
dropped to 47.78 microns compared with the 
control group (66.93 microns), indicating a decrease 
in testicular spermatogenesis activity during 
chemotherapy treatment. The epithelial thickness 
reduction and cell density reduction of the germinal 
epithelial tissue of tubules can also be seen in 
relevant tissue images. In the co-treatment vitamin 
E receiving group, a significant increase in the 
thickness of the germinal epithelium up to 58.35 
microns was observed, and it is essential to note 
that such an increase is seen in the retinoic acid and 
vitamin E co-treatment groups. In the co-treatment 
group, this parameter reached 56.53 microns.  
In contrast, in the group that received retinoic acid 
just with cyclophosphamide, the increase in 
epithelial thickness was less and was 
45.24 microns, which is less than the control group, 
and this could point to the more prominent role of 
vitamin E in protecting sexual epithelium. A similar 
pattern has been observed in central seminiferous 
tubules.  
A B 
The Study of the Protective Effect of Vitamin E and Retinoic Acid …                                                Karimi A, et al. 
Archives of Medical Laboratory Sciences; Volume 6, 2020 (Continuous Volume)  6 
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License 
The mean diameter of seminiferous tubules in the 
control groups is cyclophosphamide, 
cyclophosphamide and vitamin E, 
cyclophosphamide, and retinoic acid, and 
cyclophosphamide, and combined treatment with 
vitamin E and retinoic acid was 73.59, 54.43, 59.41, 
49.79, and 54.02 microns, respectively. Comparing 
the average tissue density in the transverse section 
of testicular tissue in different groups shows a 
decrease in the diameter of the tubules in the 
cyclophosphamide receiving group. As shown in 
the tissue density diagram in this group, the highest 
number of seminiferous tubules per surface unit has 
been recorded, which means that the sperm-
producing tubules' diameter has decreased (20.44). 
In the control and vitamin E groups, the lowest 
density was recorded with relatively equal values, 
which means that vitamin E was able to restore the 
testicular tissue conditions to the control range in 
terms of the seminiferous tubules' diameter and 
density per surface unit. The retinoic acid-receiving 
group was unable to restore conditions to normal 
situations as much as vitamin E, and the retinoic 
acid and vitamin E-receiving group had a slightly 
lower positive effect than the vitamin E group 
alone. 
The TDI index means the percentage of 
seminiferous tubules that have more than three 
differentiated cell layers. In transverse sections, the 
higher the TDI index, the higher the normal 
progression of spermatogenesis, and the higher the 
spermatogenesis level of the testicle. In the 
cyclophosphamide receiving group, the TDI index 
decreased to less than half of the control value 
(42.25), and the vitamin E receiving group 
increased it only 76.50%, while in the control 
group, the tubular differentiation index was 
98.50%, and in the retinoic acid receiving group, 
the index was 84.75%, higher than the vitamin E 
group, and in the vitamin E and retinoic acid 
combined treatment group, the index was 86.75%. 
Still, vitamin A has not been able to prevent 
oxidative stress due to cell aging. In this study, 
vitamin E resulted in a reduction in the immune 
response due to aging in peripheral blood 
lymphocytes. This process was mediated by 
reducing the effects of natural oxidative stress on 
aged cells. A similar study by Hosseini et al. shows 
that cyclophosphamide treatment leads to toxicity in 
the male reproductive system. Low doses of 
cyclophosphamide for 50 days cause severe tissue 
damage and a significant reduction in the rate of 
tubal differentiation coefficient and spermiogenesis. 
According to these studies, the number of disrupted 
tubules and interstitial space in the 
cyclophosphamide-receiving testicular tissue 
increases. The oxidative stress induction in the 
tissue is this compound and its metabolites (11). 
According to a study by Rezaei and Ahmadi in 
2015, this drug significantly reduced sperm motility 
and viability, and Imidin co-treatment improved 
many parameters and removed cyclophosphamide 
side effects in the reproductive system of Syrian 
mice (12). Reviews of vitamin E effects on 
spermatogenesis also suggest that while taking 
vitamin E supplementation can prevent the severe 
adverse effects of oxidative stress on 
spermatogenesis (13), by reducing oxidative stress 
at the same time, this vitamin improves sperm 
concentration and motility and male fertility (14). In 
a study of the spermatogenesis process of phenol-
treated rats, it was found that vitamin E was able to 
significantly improve testicular weight loss and 
tissue changes due to this substance and reach it to 
the control group. Also, the mean thickness of 
seminiferous epithelium in the vitamin E group 
showed a significant increase compared to the 
control group (15). Vitamin E has been shown to 
reduce the weight of the testicles produced by these 
toxins, as in studies of the protective effect of 
vitamin E against oxidative damage caused by 
formaldehyde (7) and sodium valproate (16) on the 
testicles. Vitamin E has been shown to reduce the 
weight loss of the testicles caused by these toxins 
and return the testicular weight to the control group 
range, as in studies of the protective effect of 
vitamin E against oxidative damage caused by 
formaldehyde (7) and sodium valproate (16) on 
mature rats testicles. It also increased antioxidant 
enzyme activity and reduced lipid peroxidation in 
the testicles, compensating for the changes caused 
by these toxins on testicular tissue, including 
reducing the diameter and atrophy of seminiferous 
tubules and returning them to normal and 
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improving Spermatogenesis. In addition to reducing 
lipid peroxidation and improving lead-induced 
histopathological changes, vitamin E has been 
shown to increase serum testosterone levels in lead-
treated rats (17). Other research has shown that 
laboratory mice with mutations in the retinoic acid 
receptor show seminiferous epithelial degeneration, 
which is very similar to the treated models for 
vitamin A deficiency (18), so the protective role of 
retinoic acid in the process of differentiating 
germinal cells is more pronounced. 
Conclusion 
In this study, cyclophosphamide has adversely 
affected spermatogenesis and testicular 
morphometric parameters, while vitamin E and 
retinoic acid as potent antioxidant agents have 
improved the destructive effects of this drug on 
testicular tissue. Vitamin E further increases the 
diameter of seminiferous tubes and maintains their 
epithelial thickness, and its protective role in these 
parameters is sufficiently valuable due to the small 
decrease in the combined treatment group. On the 
other hand, retinoic acid has a direct effect on 
increasing the TDI index in the seminiferous 
tubules, forcing the germinal cells to accelerate the 
cell cycle and the developmental process. 
Therefore, the use of vitamin E in support of 
testicular tissue during cyclophosphamide 
chemotherapy has been evaluated with a positive 
effect, and the use of retinoic acid requires 
additional studies to investigate its effects after 
completion of the chemotherapy and antioxidant co-
treatment course and suggested during a 
spermatogenesis cycle to accelerate the 
differentiation induction. This study's findings are a 
primary step in clarifying the existence of an 
unforeseen effect similar to synergism in the 
combined administration of these two vitamins. 
Based on the results of this study, corn oil had a 
small negative effect on motility, viability, 
morphology, testicular weight, and mouse weight 
which was not statistically significant.  
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